Mon, Jan 26, 2015, 12:29 AM EST - U.S. Markets open in 9 hrs 1 mins

Recent

% | $
Quotes you view appear here for quick access.

Sanofi Message Board

  • phlip.mark phlip.mark May 29, 2010 11:31 AM Flag

    Biodel - BIOD Read further folks.

    I hope Sanofi is not passing up this opportunity to its competitors. They have excellent products like ViaTab as well.


    The company has said that it cannot afford to bring VIAject to market by itself and will be looking for a partner from Big Pharma in the coming year. Leerink Swann’s Schimmer thinks that Sanofi-Aventis (SNY) will be an ideal partner for the little biotech. “Sanofi has the best selling long-acting insulin, Lantus, but its fast-acting insulin, Apidra, has fared poorly in the marketplace. By substituting VIAject for Apidra, Sanofi can offer a more compelling combination of ultra-fast and long acting insulins,” wrote Schimmer.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
SNY
46.88+0.150(+0.32%)Jan 23 4:03 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.